Magnésium Marin
Food supplement declared in France, declaration No 2021-9-1351
Magnésium Marin (Ortifo) is a food supplement declared in France. Status: retiré du marché le 13 June 2026. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- Ortifo
- Food business operator placing the product on the market
- BioUltime
- Status
- Retiré du marché le 13 June 2026
- Form
- Comprimé
- Daily dose
- 1 comprimé
- Directions for use
- 1 comprimé par jour à avaler avec un verre d’eau au moment du repas
- Not recommended for (according to the manufacturer)
- Adolescents (moins de 18 ans)
Declaration 208198, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Information
Retiré du marché le 13 June 2026, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Lithothamnion calcareum (Pallas) Areschoug | Thalle | Poudre (de plantes séchées ou broyées) | 200 mg |
Other active ingredients
| Name | Per day |
|---|---|
| Taurine | not declared |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| Acide ptéroylmonoglutamique | Folates (vitamine B9) | 1,000 µg | 200 µg |
| Oxyde de magnésium | Magnésium | 250 mg | 300 mg |
| Chlorhydrate de pyridoxine | Vitamine B6 | 12 mg | 2 mg |
Additives
E460, E170, E470b, E504
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Femmes enceintes ou allaitantes, consulter un professionnel de santé avant utilisation. Déconseillé chez les enfants, les adolescents et les personnes souffrant de troubles de la thyroïdie. Peut provoquer des effets laxatifs chez certaines personnes.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
This name is used by more than 10 declarations from different companies, so it does not identify one product. See every declaration with this name.
Brand : Ortifo